[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346048-105":59,"doc-detail-346048-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","discern-inferring-drug-sensitivity-from-single-cell-transcriptomes-using-cell-type-specific-genetic-interaction-networks-drug-sensitivity","DISCERN - inferring drug sensitivity from single-cell transcriptomes using cell-type-specific genetic interaction networks - drug sensitivity","","Genetic interactions such as synthetic lethality (SL) and synthetic viability (SV) are essential for revealing tumor-specific vulnerabilities and mechanisms behind drug resistance, yet single-cell prediction of drug response based on SL/SV remains difficult. DISCERN builds a cell-type-specific atlas of SL/SV networks across 14 human cancers using scRNA-seq datasets and uses malignant-cell genetic interactions to infer single-cell drug sensitivity. The study reconstructs prognostic SL/SV patterns involving malignant cells and T cells, improves predictive performance for lung and breast cancers, and provides CellGIdb for exploratory analysis of genetic interactions in drug response and immunotherapy.",{"@graph":69,"@context":118},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/discern-inferring-drug-sensitivity-from-single-cell-transcriptomes-using-cell-type-specific-genetic-interaction-networks-drug-sensitivity/346048/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/discern-inferring-drug-sensitivity-from-single-cell-transcriptomes-using-cell-type-specific-genetic-interaction-networks-drug-sensitivity/346048.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114],{"name":109,"@type":110,"acceptedAnswer":111},"What is DISCERN and what problem does it address?","Question",{"text":112,"@type":113},"DISCERN is a computational framework that infers single-cell drug sensitivity by leveraging cell-type-specific malignant genetic interactions. It targets the challenge of predicting drug response at single-cell resolution using synthetic lethality (SL) and synthetic viability (SV).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What performance evidence and datasets support DISCERN?",{"text":117,"@type":113},"DISCERN effectively infers tumor cell-specific drug sensitivity in scRNA-seq datasets from lung and breast cancers. It also shows improved predictive performance compared with existing computational methods.","https://schema.org",{"og:url":83,"og:type":120,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":122,"canonical":83},"index,follow",{"doc_id":124,"site_id":62},346048,1790457514,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":92,"user_avatar":129,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":135,"language":136,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":67,"update_tm":140,"read_time":141,"preview_page_count":19,"preview_urls":142},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Liu et al. Genome Medicine (2026) 18:127  \n[https://doi.org/10.1186/s13073-026-01688-w](https://doi.org/10.1186/s13073-026-01688-w)  \nGenome Medicine  \nRESEARCH Open Access  \nDISCERN: inferring drug sensitivity from single-cell transcriptomes using celltype-specific genetic interaction networks  \nMingyue Liu1,2†, Yu Tian1†, Yuchao Jia1†, Jiewei Zhang1, Xi Yi1, Shaocong Sang1, Nan Zhang1, Kaidong Liu 1, Yunyi Peng1, Yuncong Wang1, Xin Li1, Bo Chen1, Haihai Liang2,3* andYunyan Gu1,3*  \nAbstract  \nBackground Genetic interactions, including synthetic lethality (SL) and synthetic viability (SV), are crucial for understanding tumor-specific vulnerabilities and mechanisms of drug resistance. However, predicting drug response at single-cell resolution based on SL and SV remains challenging.  \nMethods Here, we construct a large-scale atlas of cell-type-specific SL and SV networks across 14 human cancers using scRNA-seq datasets. Based on this atlas, we develop DISCERN (Drug response Inference from Single-Cell gEnetic inteRactioNs), a novel computational framework designed to infer single-cell drug sensitivity by utilizing malignant cell-specific genetic interactions. We also establish CellGIdb, an interactive portal that provides the cell-type-specific genetic interaction networks.  \nResults We reconstruct cell-type-specific genetic interaction networks across cancers, revealing both shared and distinct patterns among cell types. Notably, SL and SV interactions derived from malignant cells and T cells exhibit prognostic value and correlate with response to immunotherapy. DISCERN effectively infers tumor cell-specific drug sensitivity in scRNA-seq datasets from lung and breast cancers. DISCERN demonstrates improved predictive performance compared with existing computational methods. CellGIdb provides user-friendly analytical tools to facilitate the exploration of genetic interactions’ roles in drug response and immunotherapy.  \nConclusions Collectively, this study provides a comprehensive atlas and a novel computational framework, DISCERN, for interpreting drug responses in the context of genetic interactions at single-cell resolution. The publicly available CellGIdb ([https://biodata.hrbmu.edu.cn/CellGIdb/index.html](https://biodata.hrbmu.edu.cn/CellGIdb/index.html)) resource will support further exploration of cell-typespecific vulnerabilities in cancer therapy.  \nKeywords Synthetic lethality, Synthetic viability, Drug prediction, Single-cell transcriptomics  \n†Mingyue Liu, Yu Tian andYuchao Jia contributed equally to this work.  \n*Correspondence:  \nHaihai Liang [lianghaihai@ems.hrbmu.edu.cn](lianghaihai@ems.hrbmu.edu.cn)[ ](lianghaihai@ems.hrbmu.edu.cn)Yunyan Gu[guyunyan@ems.hrbmu.edu.cn](guyunyan@ems.hrbmu.edu.cn)  \n1Department of Systems Biology, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, China 2Department of Pharmacology (State Key Laboratory-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin 150081, China  \n3State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Cr","cbCaifHG7GqKSFvQ","https://ap.wps.com/l/cbCaifHG7GqKSFvQ","pdf",8609519,14,"English","# Background\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is DISCERN and what problem does it address?\",\"answer\":\"DISCERN is a computational framework that infers single-cell drug sensitivity by leveraging cell-type-specific malignant genetic interactions. It targets the challenge of predicting drug response at single-cell resolution using synthetic lethality (SL) and synthetic viability (SV).\"},{\"question\":\"What performance evidence and datasets support DISCERN?\",\"answer\":\"DISCERN effectively infers tumor cell-specific drug sensitivity in scRNA-seq datasets from lung and breast cancers. It also shows improved predictive performance compared with existing computational methods.\"}]","DISCERN - inferring drug sensitivity from single-cell transcriptomes using cell-type-specific genetic interaction networks - drug sensitivity | PDF",1790059855,35,[143,147,151,155],{"page_no":8,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e53e503758a44bb5181d4ac9cdf645b4.webp",983,1310,{"page_no":14,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80506927ab24978d2548ecf4e8cc7b43.webp",982,1309,{"page_no":81,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/351e487e05899b31d3a9ab304cfa4805.webp",981,1308,{"page_no":19,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e6138c0e0910a48769a90c0e7f30cd9.webp",980,1306]